Winton Group LTD Durect Corp Transaction History

Winton Group LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$1.65 - $2.43 $302,169 - $445,013	-183,133 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$1.6 - $2.35 $101,937 - $149,720	-63,711 Reduced 25.81%	183,133 $313,000
Q2 2020 Aug 05, 2020	SELL	$1.33 - $2.76 $26,214 - $54,399	-19,710 Reduced 7.39%	246,844 $573,000
Q1 2020 May 11, 2020	BUY	$0.97 - $2.85 $20,999 - $61,699	21,649 Added 8.84%	266,554 $413,000
Q4 2019 Feb 13, 2020	SELL	$1.69 - $3.8 $412,689 - $927,941	-244,195 Reduced 49.93%	244,905 $931,000
Q3 2019 Nov 08, 2019	BUY	$0.61 - $2.21 $298,351 - $1.08 Million	489,100 New	489,100 $900,000

599K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $194M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.